Literature DB >> 26386570

Risk factors and serological markers of liver cirrhosis after Fontan procedure.

Mikiko Shimizu1, Kenji Miyamoto1, Yunosuke Nishihara2, Gaku Izumi1, Shuji Sakai2, Kei Inai1, Toshio Nishikawa3, Toshio Nakanishi4.   

Abstract

Liver cirrhosis (LC), which may result in hepatic failure or cancer, has been reported in patients after Fontan procedure. The purpose of this study was to clarify the frequency and histological characteristics of LC, and to evaluate the risk factors and serological markers of LC with Fontan circulation. Retrospective review of contrast-enhanced CT scans (CT) of the liver was carried out in 57 patients after Fontan procedure. Patients were divided into two groups: LC group (n = 31) and no LC group (n = 26). Age at Fontan procedure, duration after Fontan procedure, catheterization data, and history of failing Fontan circulation were compared between groups. Serological data including γ-GTP and hyaluronic acid were compared. Histology of autopsy specimens was assessed when available. Duration after Fontan procedure was significantly longer in LC group than no LC group. History of failing Fontan circulation was more frequent in LC group than in no LC group. There was no correlation between type of procedure (APC/Bjork/lateral tunnel/TCPC) and LC in this series. Serum hyaluronic acid, γ-GTP, and Forns index were significantly higher in LC group. Significant risk factors for LC were duration after Fontan procedure (>20 years). In autopsy specimens, histopathological changes of LC were observed predominantly in the central venous area. LC diagnosed with CT is frequent in patients long after Fontan procedure, especially after 20 years. Hyaluronic acid and γ-GTP could be useful markers to monitor the progression of liver fibrosis in Fontan patients.

Entities:  

Keywords:  CT scan; Failing Fontan circulation; Fontan procedure; Liver cirrhosis; Serological marker

Mesh:

Substances:

Year:  2015        PMID: 26386570     DOI: 10.1007/s00380-015-0743-4

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  23 in total

1.  Clinical profiles of adult patients with single ventricular physiology.

Authors:  Noriko Motoki; Hideo Ohuchi; Aya Miyazaki; Osamu Yamada
Journal:  Circ J       Date:  2009-07-28       Impact factor: 2.993

2.  Surgical repair of tricuspid atresia.

Authors:  F Fontan; E Baudet
Journal:  Thorax       Date:  1971-05       Impact factor: 9.139

3.  Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver.

Authors:  B Maharaj; R J Maharaj; W P Leary; R M Cooppan; A D Naran; D Pirie; D J Pudifin
Journal:  Lancet       Date:  1986-03-08       Impact factor: 79.321

4.  Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model.

Authors:  Xavier Forns; Sergi Ampurdanès; Josep M Llovet; John Aponte; Llorenç Quintó; Eva Martínez-Bauer; Miquel Bruguera; Jose Maria Sánchez-Tapias; Juan Rodés
Journal:  Hepatology       Date:  2002-10       Impact factor: 17.425

5.  Increased platelet reactivity and significant changes in coagulation markers after cavopulmonary connection.

Authors:  H B Ravn; V E Hjortdal; E V Stenbog; K Emmertsen; O Kromann; J Pedersen; K E Sorensen
Journal:  Heart       Date:  2001-01       Impact factor: 5.994

6.  Systemic oxygen saturation and coagulation factor abnormalities before and after the fontan procedure.

Authors:  Eddie W Y Cheung; George W Chay; Edmond S K Ma; Yiu-fai Cheung
Journal:  Am J Cardiol       Date:  2005-10-14       Impact factor: 2.778

7.  Serial Doppler assessment of diastolic function before and after the Fontan operation.

Authors:  Margarete Olivier; Patrick W O'leary; V Shane Pankratz; Christine M Lohse; Barbara E Walsh; A Jamil Tajik; James B Seward
Journal:  J Am Soc Echocardiogr       Date:  2003-11       Impact factor: 5.251

8.  Serum hyaluronic acid concentration in Fontan circulation: correlation with hepatic function and portal vein hemodynamics.

Authors:  Taiyu Hayashi; Ryo Inuzuka; Takahiro Shindo; Yoichiro Hirata; Nobutaka Shimizu; Akira Oka
Journal:  Pediatr Cardiol       Date:  2013-10-26       Impact factor: 1.655

9.  Noninvasive assessment of liver fibrosis in patients with Fontan circulation using transient elastography and biochemical fibrosis markers.

Authors:  Mireen Friedrich-Rust; Constanze Koch; Axel Rentzsch; Christoph Sarrazin; Peter Schwarz; Eva Herrmann; Angelika Lindinger; Ulrike Sarrazin; Thierry Poynard; Hans-Joachim Schäfers; Stefan Zeuzem; Hashim Abdul-Khaliq
Journal:  J Thorac Cardiovasc Surg       Date:  2008-03       Impact factor: 5.209

10.  Needle liver biopsy in thalassaemia: analyses of diagnostic accuracy and safety in 1184 consecutive biopsies.

Authors:  E Angelucci; D Baronciani; G Lucarelli; M Baldassarri; M Galimberti; C Giardini; F Martinelli; P Polchi; V Polizzi; M Ripalti
Journal:  Br J Haematol       Date:  1995-04       Impact factor: 6.998

View more
  11 in total

1.  Endomyocardial fibrosis: missing tricuspid valve and Fontan-like circulation.

Authors:  Yasuyuki Shiraishi; Takashi Kohno; Yoko Fujii-Nishimura; Masayuki Shimoda; Yoshihiko Ikeda; Kazuaki Nakajima; Takahiko Nishiyama; Nobuhiro Nishiyama; Mitsushige Murata; Yuichiro Maekawa; Motoaki Sano; Keiichi Fukuda
Journal:  Heart Vessels       Date:  2016-01-08       Impact factor: 2.037

2.  Significance of right atrial tension for the development of complications in patients after atriopulmonary connection Fontan procedure: potential indicator for Fontan conversion.

Authors:  Gaku Izumi; Hideaki Senzaki; Atsuhito Takeda; Hirokuni Yamazawa; Kohta Takei; Takuo Furukawa; Kei Inai; Tokuko Shinohara; Toshio Nakanishi
Journal:  Heart Vessels       Date:  2017-01-07       Impact factor: 2.037

3.  Forns Index is a predictor of cardiopulmonary bypass time and outcomes in Fontan conversion.

Authors:  Gaku Izumi; Atsuhito Takeda; Hirokuni Yamazawa; Osamu Sasaki; Nobuyasu Kato; Hidetsugu Asai; Tsuyoshi Tachibana; Yoshiro Matsui
Journal:  Heart Vessels       Date:  2019-09-27       Impact factor: 2.037

4.  A case of Fontan-related hepatocellular carcinoma successfully treated with proton beam therapy.

Authors:  Yuri Ogasawara; Tomomi Kogiso; Takaomi Sagawa; Kazuhisa Kodama; Makiko Taniai; Haruko Numajiri; Hideyuki Sakurai; Katsutoshi Tokushige
Journal:  Clin J Gastroenterol       Date:  2019-07-04

Review 5.  Screening modalities for the diagnosis of Fontan-associated liver disease: evidence from the past for future development.

Authors:  Saviga Sethasathien; Krit Leemasawat; Suchaya Silvilairat; Rekwan Sittiwangkul; Siriporn C Chattipakorn; Nipon Chattipakorn
Journal:  Am J Transl Res       Date:  2022-03-15       Impact factor: 4.060

6.  Hepatic Changes in the Fontan Circulation: Identification of Liver Dysfunction and an Attempt to Streamline Follow-up Screening.

Authors:  T Ackerman; A Geerts; H Van Vlierberghe; J De Backer; K François
Journal:  Pediatr Cardiol       Date:  2018-07-21       Impact factor: 1.655

Review 7.  From congestive hepatopathy to hepatocellular carcinoma, how can we improve patient management?

Authors:  Anna Sessa; Manon Allaire; Pascal Lebray; Mourad Medmoun; Alberto Tiritilli; Pierre Iaria; Jean-François Cadranel
Journal:  JHEP Rep       Date:  2021-01-27

Review 8.  Abdominal imaging findings in adult patients with Fontan circulation.

Authors:  Tae-Hyung Kim; Hyun Kyung Yang; Hyun-Jung Jang; Shi-Joon Yoo; Korosh Khalili; Tae Kyoung Kim
Journal:  Insights Imaging       Date:  2018-04-05

9.  Fontan-associated liver disease and hepatocellular carcinoma in adults.

Authors:  Tomomi Kogiso; Katsutoshi Tokushige
Journal:  Sci Rep       Date:  2020-12-10       Impact factor: 4.379

10.  Long-term results of additional pulmonary blood flow with bidirectional cavopulmonary shunt.

Authors:  Ryosuke Kowatari; Yasuyuki Suzuki; Kazuyuki Daitoku; Ikuo Fukuda
Journal:  J Cardiothorac Surg       Date:  2020-09-29       Impact factor: 1.637

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.